BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10073795)

  • 1. Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis.
    Shohet RV; Anwar A; Johnston JM; Cohen JC
    Am J Cardiol; 1999 Jan; 83(1):109-11, A8-9. PubMed ID: 10073795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease.
    Caslake MJ; Packard CJ; Suckling KE; Holmes SD; Chamberlain P; Macphee CH
    Atherosclerosis; 2000 Jun; 150(2):413-9. PubMed ID: 10856534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma platelet-activating factor degradation in patients with severe coronary artery disease.
    Graham RM; Stephens CJ; Sturm MJ; Taylor RR
    Clin Sci (Lond); 1992 May; 82(5):535-41. PubMed ID: 1317763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum platelet-activating factor acetylhydrolase during coronary artery bypass surgery.
    Nathan N; Cornu E; Denizot Y; Feiss P; Arnoux B
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):254-5. PubMed ID: 8204819
    [No Abstract]   [Full Text] [Related]  

  • 5. Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction.
    Stephens CJ; Graham RM; Sturm MJ; Richardson M; Taylor RR
    Coron Artery Dis; 1993 Feb; 4(2):187-93. PubMed ID: 8269210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis.
    Graham RM; Stephens CJ; Silvester W; Leong LL; Sturm MJ; Taylor RR
    Crit Care Med; 1994 Feb; 22(2):204-12. PubMed ID: 8306677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor acetylhydrolase in human seminal plasma.
    Letendre ED; Miron P; Roberts KD; Langlais J
    Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions].
    Kawamura Y; Satoh K; Takamatsu S; Mizuno S
    Rinsho Byori; 1987 Oct; 35(10):1149-53. PubMed ID: 3437547
    [No Abstract]   [Full Text] [Related]  

  • 9. Human plasma platelet-activating factor acetylhydrolase.
    Stafforini DM; Tjoelker LW
    Methods Mol Biol; 1999; 109():49-58. PubMed ID: 9918011
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet-activating factor-acetylhydrolase activity in maternal and umbilical venous plasma obtained from normotensive and hypertensive pregnancies.
    Kobayashi F; Sagawa N; Ihara Y; Kitagawa K; Yano J; Mori T
    Obstet Gynecol; 1994 Sep; 84(3):360-4. PubMed ID: 8058231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction.
    Serebruany VL; Gurbel PA; Murugesan SR; Lowry DR; Sturm E; Svetlov SI
    Cardiology; 1998 Oct; 90(2):127-30. PubMed ID: 9778550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia.
    Gaylord MS; Smith ZL; Lorch V; Blank ML; Snyder F
    Am J Med Sci; 1996 Oct; 312(4):149-54. PubMed ID: 8853062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor acetylhydrolase activity in peritoneal fluids of women with endometriosis.
    Hemmings R; Miron P; Falcone T; Bourque J; Lepage N; Langlais J
    Obstet Gynecol; 1993 Feb; 81(2):276-9. PubMed ID: 8423963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet-activating factor-acetylhydrolase activity in the umbilical venous plasma of growth-restricted fetuses.
    Ohshige A; Yoshimura T; Maeda T; Ito M; Okamura H
    Obstet Gynecol; 1999 Feb; 93(2):180-3. PubMed ID: 9932551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
    Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
    J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor-acetylhydrolase activity in normotensive and hypertensive pregnancies.
    Maki N; Magness RR; Miyaura S; Gant NF; Johnston JM
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):50-4. PubMed ID: 8420347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
    Parks JE; Hough SR
    J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease.
    Goudevenos J; Tselepis AD; Tsoukatos D; Grekas G; Kritikakos J; Sideris D
    Eur Heart J; 1995 Aug; 16(8):1036-43. PubMed ID: 8665964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of platelet-activating factor acetylhydrolase exists in red cell membrane.
    Yoshida H; Satoh K; Imaizumi T
    Am J Hematol; 1992 May; 40(1):61-3. PubMed ID: 1566749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia.
    Jehle R; Schlame M; Büttner C; Frey B; Sinha P; Rüstow B
    Biochim Biophys Acta; 2001 May; 1532(1-2):60-6. PubMed ID: 11420174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.